|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/12 | |
| A61K 31/404 | |||
| A61P 35/00 | |||
| C07D 209/32 | |||
| C07D 211/96 | |||
| C07D 213/64 | |||
| C07D 215/20 | |||
| C07D 217/16 | |||
| C07D 235/26 | |||
| C07D 249/04 | |||
| C07D 295/14 | |||
| C07D 309/14 | |||
| C07D 401/12 | |||
| C07D 295/125 | |||
| C07D 231/56 | |||
| C07D 405/14 |
| (11) | Number of the document | 2507229 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10727241.1 |
| Date of filing the European patent application | 2010-06-01 | |
| (97) | Date of publication of the European application | 2012-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/036919 |
| Date | 2010-06-01 |
| (87) | Number | WO 2011/068561 |
| Date | 2011-06-09 |
| (30) | Number | Date | Country code |
| 631404 | 2009-12-04 | US |
| (72) |
PARK, Chang, H., US
BRUNCKO, Milan, US
DING, Hong, US
DOHERTY, George A., US
ELMORE, Steven, W., US
HASVOLD, Lisa, US
HEXAMER, Laura, US
KUNZER, Aaron, US
MANTEI, Robert, A., US
McCLELLAN, William, J., US
PARK, Cheol-Min, US
PETROS, Andrew, M., US
SONG, Xiaohong, US
SOUERS, Andrew, J., US
SULLIVAN, Gerard, M., US
TAO, Zhi-Fu, US
WANG, Gary, T., US
WANG, Le, US
WANG, Xilu, US
WENDT, Michael, D., US
HANSEN, Todd, M., US
|
| (73) |
AbbVie Inc.,
1 North Waukegan Road, North Chicago, IL 60064,
US
|
| (54) | SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES |
| SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES |